Therapeutic Options in Hereditary Optic Neuropathies.

Although the primary end-point did not reach statistical significance, all secondary end-points showed a consistent positive trend in treated patients compared to the placebo group [ 11 ], whose VA kept deteriorating as expected by natural history [ 79 ].

also in 111,027 other papers